Tang Capital Management LLC Bei Gene, Ltd. Transaction History
Tang Capital Management LLC
- $1.17 Billion
- Q3 2024
A detailed history of Tang Capital Management LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Tang Capital Management LLC holds 37,000 shares of BGNE stock, worth $8.39 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
37,000
Previous 37,000
-0.0%
Holding current value
$8.39 Million
Previous $5.28 Million
57.37%
% of portfolio
0.71%
Previous 0.64%
Shares
4 transactions
Others Institutions Holding BGNE
# of Institutions
252Shares Held
45.3MCall Options Held
292KPut Options Held
119K-
Baker Bros. Advisors LP New York, NY10.6MShares$2.4 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.46 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$1.17 Billion26.65% of portfolio
-
Primecap Management CO Pasadena, CA4.97MShares$1.13 Billion0.84% of portfolio
-
Baillie Gifford & CO3.67MShares$832 Million0.54% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $23.5B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...